Home » Posts tagged with » Perceptive Advisors
US medical device company Adagio Medical raises $42.5m in Series E

US medical device company Adagio Medical raises $42.5m in Series E

Adagio Medical, a California-based medical device company focused on developing treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), has raised $42.5 million in a Series E equity financing round. The company has also developed the intelligent Continuous Lesion Ablation System (iCLAS). Its Series E financing round included new investors ArrowMark Partners, Perceptive Advisors, and […]

November 15, 2020No CommentRead More

Gene therapy company 4D Molecular Therapeutics raises $70m in Series C round

June 17, 2020 No Comment
Gene therapy company 4D Molecular Therapeutics raises $70m in Series C round

California-based gene therapy company 4D Molecular Therapeutics (4DMT), which is focused on adeno-associated virus (AAV) gene therapy vector discovery and product development, has raised $70 million through a Series C financing round. The Series C financing round was led by Viking Global Investors. It also saw participation from new investors such as Amzak Health, Casdin […]

Continue reading …

Lyra Therapeutics raises $30m for chronic rhinosinusitis drug candidates

February 1, 2020 No Comment
Lyra Therapeutics raises $30m for chronic rhinosinusitis drug candidates

Lyra Therapeutics has raised $30 million in a Series C financing round to advance its lead product candidates for the treatment of chronic rhinosinusitis (CRS). Known as an inflammatory disease of the paranasal sinuses, chronic rhinosinusitis is said to affect around 14 million people in the US. The lead product candidates of the US-based clinical-stage […]

Continue reading …

Landos Biopharma secures $60m in Series B financing round

August 14, 2019 No Comment
Landos Biopharma secures $60m in Series B financing round

Landos Biopharma, a US clinical-stage pharma company focused on the discovery and development of oral therapeutics for autoimmune diseases, has closed a $60 million Series B financing round. The financing round was co-led by RTW Investments and Perceptive Advisors (Perceptive Xontogeny Venture Fund and Perceptive Life Sciences Fund). Osage University Partners and PBM Capital were […]

Continue reading …